Comparing Symmetric Dimethylarginine and Amyloid-β42 as Predictors of Alzheimer’s Disease Development is a research paper published in Journal of Alzheimer s Disease Reports (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R01 AG046171
NIA NIH HHS
Grant: RF1 AG051550
NIA NIH HHS
Grant: U01 AG024904
National Institutes of Health
Grant: 3RF1AG051550-01S1
Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias
National Institutes of Health
Grant: 5R01AG046171-03
Metabolic Networks and Pathways in Alzheimer's Disease
National Institutes of Health
Grant: 3U01AG024904-09S4
ADNI Duke Supplement
Canadian Institutes of Health Research
Grant: unidentified
unidentified
FWCI
0.14
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals